EGFR and breast carcinoma: Ginsenoside Rh2 combined with EGFR-targeted liposomes can inhibit tumor growth and metastasis in breast cancer [679].Thus, the combination of ginsenosides with other therapeutic agents, including chemotherapy drugs, targeted therapies, natural products, and immunotherapies, significantly enhances their anti-cancer effects.